Posters

Details of posters presented at the 2009 conference are below, where permission has been given they are available to download as a pdf by clicking on the title

Meningitis Research Foundation would like to thank Wyeth Vaccines for kindly donating the prize for best poster. The joint winners of this year's poster prize were

Back to conference home

Author Poster Title Institution Pathogen Topic
Baharak Afshar Overview of Group B Streptococcal screening and laboratory diagnostics in Europe Respiratory and Systemic Infections Department, HPA, London Group B Streptococcal Diagnosis
Lorraine Als Neuropsychological function in children following acute severe paediatric illness. Academic Unit of Child & Adolescent Psychiatry, Imperial College London Meningitis & septicaemia Outcome
Lorraine Als Salivary cortisol and alpha-amylase levels following admission to Paediatric Int ensive Care Academic Unit of Child and Adolescent Psychiatry, Imperial College London, London, UK Meningitis & septicaemia Outcome, pathophysiology and treatment
Xilian Bai Immunogenicity of an investigational recombinant meningococcal vaccine with and without outer membrane vesicles, against a group B strain representative of the Normandy outbreak. Vaccine Evaluation Unit, Health Protection Agency, Manchester Meningococcal Vaccine
Xilian Bai Comparison of complement sources in the meningococcal serogroup B serum bactericidal antibody assay Vaccine Evaluation Unit, Health Protection Agency, Manchester Meningococcal Vaccine
Chris Bailey A novel vaccine approach for Neisseria meningitidis; heat shock protein-antigen complexes (HspC) demonstrate cross-serogroup immunogenicity ImmunoBiology Ltd., Babraham Research Campus, Babraham, Cambridge Meningococcal Vaccine
Chris Bayliss Phase Variation of NadA, PorA and Other Surface Proteins During Meningococcal Carriage Department of Genetics, University of Leicester, Leicester, UK Meningococcal Vaccine
Chris Bayliss Influence of the Combination and Phase Variation Status of the Haemoglobin Receptors on Meningococcal Virulence Department of Genetics, University of Leicester, Leicester, UK Meningococcal Pathogenesis
Rachel Bigwood Exploring the expression levels of recombinant antigens and the murine response to Novartis recombinant MenB investigational vaccine NIBSC, National Institute for Biological Standards and Control, Health Protection Agency, Potters Bar, Herts Meningococcal Vaccine
Barbara Bolgiano Pre-clinical testing of the Meningitis Vaccine Project’s monovalent MenA-TT conjugate vaccine Division of Bacteriology, National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, Potters Bar Meningococcal Vaccine
Charlotte Brookes Correlation of high-throughput flow cytometry assays with live killing assays in the assessment of meningococcal vaccines. Health Protection Agency, Centre of Emergency Preparedness and Response, Porton Down, Salisbury, UK Meningococcal Vaccine
Suzana Bukovski Follow up of Invasive Bacterial Diseases at University Hospital for Infectious Diseases “Dr Fran Mihaljević” Zagreb, Croatia – January to July 2009 University Hospital for Infectious Diseases, Department of Clinical Microbiology, Zagreb Meningitis & septicaemia Outcome
Karena Burkin Immunogenicity and thermal stability of a combined vaccine against Haemophilus influenzae type b and Neisseria meningitidis group C Division of Bacteriology, National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, Potters Bar Meningococcal Vaccine
Katherine Cartwright Factors contributing to the high mortality of adults with bacterial meningitis in Malawi Dept of Microbiology, Leicester Royal Infirmary, Leicester, UK Bacterial meningitis Treatment / Outcome
Ana Cehovin Minor pili as novel vaccine candidates against Neisseria meningitidis The Centre for Molecular Microbiology and Infection, Flowers Building, Imperial College London Meningococcal Vaccine
Laura Clark Findings from the 2003 Meningitis Research Foundation member survey Meningitis Research Foundation / University of Bristol Meningitis & septicaemia Outcome
Ida Czumbel The epidemiology of invasive meningococcal disease in Europe, 2007 European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Meningococcal Vaccine
Jesper Damsgaard Viral meningitis – a study of post-infectious cognitive dysfunction and associated neuropathology Department of Infectious Diseases, Aarhus University Hospital, Skejby, Denmark Viral meningitis Outcome
Peter Dull Evaluation of polysaccharide and investigational meningococcal conjugate quadrivalent (ACWY) vaccines in adolescents by serum bactericidal assay using rabbit (rSBA) or human complement (hSBA) Clinical Research, Novartis Vaccines and Diagnostics, Cambridge MA, USA Meningococcal Vaccine
Rachel M. Exley A Conserved major pilin subunit in Neisseria meningitidis Centre for Molecular Microbiology and Infection, Department of Infectious Disease, Flowers Building, Imperial College London Meningococcal Vaccine
Helen Findlow Meningococcal group C and W135 immunological hyporesponsiveness in African toddlers HPA, Manchester Meningococcal Vaccine
Helen Findlow Competitive inhibition flow analysis assay for the non-culture detection of pneumococcal serotype capsular polysaccharide. HPA, Manchester Pneumococcal Diagnosis
Helen Freeman Staphylococcus aureus sepsis on PICU. Bristol Royal Hospital for Children Staphylococcal Pathophysiology
Fang Gao Pneumococcal conjugate vaccine stability from a physico-chemical point-of-view Division of Bacteriology, National Institute for Biological Standards and Control, Health Protection Agency, South Mimms, Potters Bar Pneumococcal Vaccine
Elizabeth Gonzalez Proteoliposome and cochleate derived from serogroups B N. meningitides for mucosal vaccines Immunology Department, Research Vice-presidency, Finlay Institute, P.O. Box 16017, Havana, Cuba Meningococcal Vaccine
Elizabeth Gonzalez Production of large scale AFCo1 as Vaccine Adjuvant Immunology Department, Research Vice-Presidency, Finaly Institute, Havana City, Cuba Meningococcal Vaccine
Elizabeth Gonzalez Mucosal and systemic immune response induced by intranasal immunisation of C polysaccharide of Neisseria meningitidis C and AFCo1 Immunology Department, Research Vice-Presidency, Finaly Institute, Havana City, Cuba Meningococcal Vaccine
Elizabeth Gonzalez Mucosal and Systemic Immune Response against Neisseria Meningitidis B Induced by Single Time Vaccination Strategy Immunology Department, Finlay Institute, P.O. Box 16017, Havana, Cuba Meningococcal Vaccine
Steve Gray The epidemiology and surveillance of meningococcal disease in England and Wales. HPA Meningococcalcoccal Reference Unit, Manchester Meningococcal Epidemiology
Tanya A Haj-Hassan Improving the early recognition of meningococcal disease in children and adolescents Department of Primary Health Care, University of Oxford Meningococcal Recognition
Jason Hinds Molecular serotyping of Streptococcus pneumoniae: a microarray-based tool with enhanced utility. St. George’s, University of London Pneumococcal Epidemiology
Lee Hudson A Survey of First-line antibiotic agent for Meningococcal Disease in Infants and Children in the England and Wales Department of General Paediatrics and Adolescent Medicine. University College Hospital London Meningococcal Treatment
Syed Islam fHBP variation and expression is independent of age, gender and disease outcome for meningococcal serogroup B disease Global Safety Surveillance & Epidemiology, Wyeth Research, Collegeville, PA, USA Meningococcal Epidemiology
Amel Kechrid Epidemiology of bacterial meningitis in Tunisian children (2000-2008) Laboratoire de Microbiologie, Hôpital d’Enfants de Tunis, Tunisie Bacterial meningitis Epidemiology
Paul B. Keiser Phase 1 study of an intramuscular meningococcal NOMV vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two porA’s and stablized Opc expression (HOPS-G). Meningococcalcoccal Vaccine Program Division of Bacterial and Rickettsial Diseases Walter Reed Army Institute of Research Meningococcal Vaccine
Matthew Kelly Prevalence of HSV, EBV and CMV in the cerebrospinal fluid of adults with clinically suspected bacterial meningitis in Malawi Dept of Medicine, College of Medicine, University of Malawi, Blantyre, Malawi Bacterial meningitis Pathophysiology and treatment
Ravi Kirubanandan Distal tibial growth arrest following meningococcal septicaemia; management and outcome of a series of 7 ankles. Department of Paediatric Orthopaedics, Bristol Royal Hospital for Sick Children, Bristol Meningococcal Outcome
Ravi Kirubanandan Sparing of the distal fibular physis in patients with physeal arrest around the ankle following Meningococcal septicaemia - a previously unreported phenomenon. Department of Paediatric Orthopaedics, Bristol Royal Hospital for Sick Children, Bristol Meningococcal Outcome
Lorna E Lancaster Structural and Immunological Characterisation of a Group B Streptococcus Conjugate Vaccine Division of Bacteriology, NIBSC, HPA Group B Streptococcal Vaccine
Jay Laver Nitric oxide metabolism of Neisseria meningitidis prevents host cell S-nitrosothiol formation: a novel mechanism of meningococcal pathogenesis. Department of Infection and Immunity, The University of Sheffield Meningococcal Pathophysiology
Yanwen Li Extensive injuries of human brain by Neisseria meningitidis infection Department of Infectious Diseases, Imperial College London Meningococcal Pathophysiology
Angela Martino Evaluation of three candidate vaccine antigens to Neisseria meningitidis in context of a recombinant protein-OMVNZ combination NIBSC - HPA, Potters Bar, Herts Meningococcal Vaccine
Anne McNaughton NarE, a novel ADPRT from Neisseria meningitidis can modulate innate and antigen specific immune responses. School of Biochemistry and Immunology, Trinity College Dublin, Ireland Meningococcal Vaccine
Elaine McAleese Is there a link? West Yorkshire Health Protection Unit Meningococcal Epidemiology
Prasadarao Nemani IL-10 administration during high-level bacteremia prevents brain damage in Escherichia coli K1 induced neonatal meningitis by increasing the pathogen clearance Division of Infectious Diseases, Childrens Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA E. Coli Pathophysiology and treatment
Philipp Oster First use of an investigational meningococcal serogroup B vaccine administered in combination with New Zealand (NZ) strain (NZ98/254) outer membrane vesicles (OMV) in healthy adults Global Medical Affairs, Novartis Vaccines, Siena, Italy Meningococcal Vaccine
Philipp Oster First use in adolescents of an investigational recombinant meningococcal B vaccine developed by reverse vaccinology Global Medical Affairs, Novartis Vaccines, Siena, Italy Meningococcal Vaccine
Rishi Patel Can we improve compliance with the algorithm for the management of children with a petechial rash and fever? – A completed Audit Cycle Leighton District General Hospital, Mid Cheshire Hospitals NHS Foundation Trust, Crewe, UK Meningococcal Recognition
Tuula Pelkonen Accuracy of Three Prognostic Scales in Childhood Bacterial Meningitis Helsinki University Central Hospital, Hospital for Children and Adolescents, Helsinki, Finland Bacterial meningitis Recognition, pathophysiology and treatment
Bruno Pichon Serotype replacement following the introduction of the PCV7 in the UK - Impact on the characteristics of pneumococci causing meningitis Respiratory and Systemic Infection Laboratory, Health Protection Agency – Centre for infections, London, UK Pneumococcal Vaccine
Kate Pryde Stroke In Paediatric Pneumococcal Meningitis Southampton University Hospitals NHS Trust, Southampton Pneumococcal Pathophysiology
Susanna Ricci The meningococcal ABC-type L-glutamate transporter GltT is necessary for the development of experimental meningitis in mice LA.M.M.B., Dept. Molecular Biology, University of Siena, Italy Meningococcal Pathogenesis
Gerwin D. Rodenburg Antibody responses after a reduced dose schedule with the pneumococcal conjugate vaccine; Timing of the booster dose in the first or second year of life Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children’s Hospital, UMC Utrecht, The Netherlands Pneumococcal Vaccine
Gerwin D. Rodenburg Lipid A variants in meningococcal disease and carriage isolates; prevalance and clinical impact Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children’s Hospital, UMC Utrecht, The Netherlands Meningococcal Epidemiology
Lisa Sacks Very early Fasciotomies prevents major limb loss in Children with Meningococcal Septicaemia. Bristol Children's Hospital, Bristol Meningococcal Outcome
Katrine Schou Bacterial and viral meningitis - Clinical manifestations, course and sequelae Infectious Disease Research Unit, Department of Infectious Diseases Q, Aarhus University Hospital, Skejby, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark Bacterial & viral meningitis Recognition, treatmemt, outcome
Elske van Gils Increase of nasopharyngeal carriage with serotype 19A after pneumococcal conjugate vaccine University Medical Center Utrecht Department of Pediatric Immunology and Infectious diseases Pneumococcal Vaccine
Elske van Gils Effect of reduced dose schedules with PCV-7 on pneumococcal carriage in children and adult contacts: a randomised controlled trial. University Medical Center Utrecht Department of Pediatric Immunology and Infectious diseases Pneumococcal Vaccine
Victoria Wright A genome-wide association study of meningococcal disease identifies novel susceptibility genes in a paediatric meningococcal patient cohort. Paediatrics, Imperial College London, UK Meningococcal Pathophysiology